Kan-Ichiro Suzuki

Director at GNI Group

After more than 20 years of experience in investment research and management consulting at Nomura Research Institute (NRI), Professor Suzuki played a major role in the development of the GNI Group as a founding member of Gene Networks, Inc (GNI), the predecessor of GNI. Since 2009, as a professor at Ritsumeikan Asia Pacific University, he has been researching leadership, organizational functions, international management, ESG management, etc., and has published numerous academic papers and books. He is an emeritus professor at the university. He graduated from Waseda University Faculty of Political Science and Economics and received a Master of Business Administration (MBA) from UNC Kenan-Flagler Business School in the United States and a Ph.D. from Waseda University Graduate School of Asia Pacific Studies. He was also a visiting scholar at the Hoover Institution at Stanford University in the United States.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


GNI Group

GNI Group Ltd. is a Japan-based company engaged in new drug production activities utilizing biotechnologies. The Company is engaged in the development of therapeutic agents for diseases that have many sufferers in Asian countries such as Japan and China, as well as clinical trial and bio-verification test businesses. It is engaged in research and development of therapeutic agents, including F647 for radiation pneumonia (RP) and idiopathic pulmonary fibrosis (IPF), F351 for liver fibrosis (cirrhosis) and F573 for acute hepatic insufficiency and acute chronic liver failure (ACLF).


Industries

Headquarters

Chuo-Ku, Japan

Employees

201-500

Links